Progress in molecular genetics of Alzheimer's disease

被引:16
|
作者
Hisama, FM
Schellenberg, GD
机构
[1] YALE UNIV, SCH MED, DEPT NEUROL, NEW HAVEN, CT 06510 USA
[2] SEATTLE VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, SEATTLE, WA USA
来源
NEUROSCIENTIST | 1996年 / 2卷 / 01期
关键词
Alzheimer's disease; dementia; molecular genetics; amyloid; neurofibrillary tangle; apolipoprotein E;
D O I
10.1177/107385849600200106
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Recent intensive work has highlighted the genetic basis of several forms of Alzheimer's disease (AD). Mutations in the amyloid precursor protein gene on chromosome 21 can cause either an early-onset autosomal dominant AD or hereditary cerebral hemorrhage with amyloidosis. On chromosome 14, a second gene associated with 70 to 90% of early-onset familiar AD (FAD) was identified by positional cloning in 1995, Still other kindreds show no linkage to either chromosome 21 or chromosome 14; the third locus (on chromosome 1) was recently identified in affected descendants of a group of families known as the Volga Germans. In late-onset (age > 65 years) AD, the apolipoprotein E gene allele epsilon 4 on chromosome 19 has clearly been shown to be a risk factor for the development of AD and appears to modify the age of onset of the disease. The emerging picture is that AD is a genetically complex, heterogeneous disorder. Precisely how these genetic factors interact with each other and with other yet-to-be-identified genetic and nongenetic (environmental) factors to produce the clinical and pathologic findings in AD remains to be elucidated.
引用
收藏
页码:3 / 6
页数:4
相关论文
共 50 条